Alternative pediatric metabolic syndrome definitions impact prevalence estimates and socioeconomic gradients

Alexander Lepe1, Marlou L A de Kroon2, Andrea F de Winter2

  • 1Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. a.lepe@umcg.nl.

Pediatric Research
|January 15, 2021
PubMed

Insights

Different definitions of pediatric metabolic syndrome (MetS) yield varying prevalence rates but consistently identify low socioeconomic status (SES) as a risk factor. This impacts comparisons of prevalence studies but not SES association studies.

Area of Science:

  • Pediatrics
  • Metabolic Health
  • Public Health

Background:

  • Lack of a standardized definition for pediatric metabolic syndrome (MetS) complicates research.
  • Existing definitions yield diverse prevalence estimates and identify different children at risk.

Purpose of the Study:

  • To assess the impact of alternative MetS definitions on prevalence and identification of affected children.
  • To evaluate how different MetS definitions influence the association with socioeconomic status (SES).

Main Methods:

  • Utilized data from the prospective, multigenerational Dutch Lifelines Cohort Study.
  • Calculated MetS prevalence using five distinct published definitions.
  • Employed logistic regression to analyze the association between MetS and SES, adjusting for covariates.

Main Results:

  • MetS prevalence varied significantly across definitions, ranging from 0.7% to 3.0% at baseline.
  • A consistent socioeconomic gradient was observed, with lower SES linked to higher MetS risk.
  • Each additional year of parental education reduced MetS odds by 8% to 19% in longitudinal analyses.

Conclusions:

  • The choice of MetS definition significantly impacts prevalence estimates and the identification of affected children.
  • Despite definition variability, low SES remains a consistent risk factor for pediatric MetS.
  • Comparisons of MetS prevalence across studies are limited by definitional differences, while SES associations are more robust.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
530
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
106
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
2.9K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
131
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.5K